GSK application for expanded use of RSV vaccine in adults aged 18-49 accepted in Japan
GSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted the company's regulatory application to expand the use of its adjuvanted recombinant respiratory syncytial virus…
